<?xml version="1.0"?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2015//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_150101.dtd">
<PubmedArticleSet>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24357295</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>08</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6165</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>20</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Breakthrough of the year 2013. ...Areas to watch in
					2014.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1443</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.342.6165.1443</ELocationID>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016433">News</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D032761">Animal
						Experimentation</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp;
						jurisprudence</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D017087">Animal Rights</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D015894">Genome, Human</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D002679">Pan troglodytes</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D035583">Rare Diseases</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D017422">Sequence
						Analysis, DNA</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>9</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6165/1443</ArticleId>
				<ArticleId IdType="doi">10.1126/science.342.6165.1443</ArticleId>
				<ArticleId IdType="pubmed">24357295</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24357294</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>08</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6165</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>20</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Breakthrough of the year 2013. How we did in 2013
					and...</ArticleTitle>
				<Pagination>
					<MedlinePgn>1442</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.342.6165.1442-b</ELocationID>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016433">News</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D001519">Behavior</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000648">ultrastructure</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D054351">Electrical
						Synapses</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D017422">Sequence
						Analysis, DNA</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D059010">Single-Cell
						Analysis</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>9</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6165/1442-b</ArticleId>
				<ArticleId IdType="doi">10.1126/science.342.6165.1442-b</ArticleId>
				<ArticleId IdType="pubmed">24357294</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24357292</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>08</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6165</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>20</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>2013 Runners-Up. Your microbes, your health.
				</ArticleTitle>
				<Pagination>
					<MedlinePgn>1440-1</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.342.6165.1440-b</ELocationID>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016433">News</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D014227">Triazines</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>N3GP2YSD88</RegistryNumber>
					<NameOfSubstance UI="C011907">melamine</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial
						Agents</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000008">administration
						&amp; dosage</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005673">Fusobacterium</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D041981">Gastrointestinal
						Tract</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D006262">Health</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D041943">Infant Formula</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007668">Kidney</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007669">Kidney Calculi</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007709">Klebsiella</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D044342">Malnutrition</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014227">Triazines</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000633">toxicity</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>9</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6165/1440-b</ArticleId>
				<ArticleId IdType="doi">10.1126/science.342.6165.1440-b</ArticleId>
				<ArticleId IdType="pubmed">24357292</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24357284</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>08</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>04</Month>
				<Day>14</Day>
			</DateRevised>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6165</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>20</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Breakthrough of the year 2013. Cancer immunotherapy.
				</ArticleTitle>
				<Pagination>
					<MedlinePgn>1432-3</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.342.6165.1432</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Couzin-Frankel</LastName>
						<ForeName>Jennifer</ForeName>
						<Initials>J</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016433">News</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000906">Antibodies</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D060908">CTLA-4 Antigen</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C508317">ipilimumab</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2013 Dec 20;342(6165):1417</RefSource>
					<PMID Version="1">24357273</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2014 Apr 11;344(6180):149</RefSource>
					<PMID Version="1">24723594</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000906">Antibodies</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000911">Antibodies,
						Monoclonal</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D060908">CTLA-4 Antigen</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D002986">Clinical Trials
						as Topic</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008545">Melanoma</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>9</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6165/1432</ArticleId>
				<ArticleId IdType="doi">10.1126/science.342.6165.1432</ArticleId>
				<ArticleId IdType="pubmed">24357284</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24357273</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>08</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6165</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>20</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Cancer immunotherapy.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1417</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1249481</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>McNutt</LastName>
						<ForeName>Marcia</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Marcia McNutt is Editor-in-Chief of Science.
							</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016420">Comment</PublicationType>
					<PublicationType UI="D016421">Editorial</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000906">Antibodies</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D060908">CTLA-4 Antigen</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="CommentOn">
					<RefSource>Science. 2013 Dec 20;342(6165):1432-3</RefSource>
					<PMID Version="1">24357284</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000906">Antibodies</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D060908">CTLA-4 Antigen</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>21</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>9</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6165/1417</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1249481</ArticleId>
				<ArticleId IdType="pubmed">24357273</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24337294</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>16</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>24</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>12</Month>
				<Day>20</Day>
			</DateRevised>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6164</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>13</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Erythropoietin derived by chemical synthesis.
				</ArticleTitle>
				<Pagination>
					<MedlinePgn>1357-60</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1245095</ELocationID>
				<Abstract>
					<AbstractText>Erythropoietin is a signaling glycoprotein that
						controls the fundamental process of erythropoiesis, orchestrating
						the production and maintenance of red blood cells. As
						administrated clinically, erythropoietin has a polypeptide
						backbone with complex dishomogeneity in its carbohydrate domains.
						Here we describe the total synthesis of homogeneous erythropoietin
						with consensus carbohydrate domains incorporated at all of the
						native glycosylation sites. The oligosaccharide sectors were built
						by total synthesis and attached stereospecifically to peptidyl
						fragments of the wild-type primary sequence, themselves obtained
						by solid-phase peptide synthesis. The glycopeptidyl constructs
						were joined by chemical ligation, followed by metal-free
						dethiylation, and subsequently folded. This homogeneous
						erythropoietin glycosylated at the three wild-type aspartates with
						N-linked high-mannose sialic acid-containing oligosaccharides and
						O-linked glycophorin exhibits Procrit-level in vivo activity in
						mice.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Ping</ForeName>
						<Initials>P</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Bioorganic Chemistry, Sloan-Kettering
								Institute for Cancer Research, 1275 York Avenue, New York, NY
								10065, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Dong</LastName>
						<ForeName>Suwei</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Shieh</LastName>
						<ForeName>Jae-Hung</ForeName>
						<Initials>JH</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Peguero</LastName>
						<ForeName>Elizabeth</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hendrickson</LastName>
						<ForeName>Ronald</ForeName>
						<Initials>R</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Moore</LastName>
						<ForeName>Malcolm A S</ForeName>
						<Initials>MA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Danishefsky</LastName>
						<ForeName>Samuel J</ForeName>
						<Initials>SJ</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>HL025848</GrantID>
						<Acronym>HL</Acronym>
						<Agency>NHLBI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P30 CA008748</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 GM109760</GrantID>
						<Acronym>GM</Acronym>
						<Agency>NIGMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 HL025848</GrantID>
						<Acronym>HL</Acronym>
						<Agency>NHLBI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D006021">Glycophorin</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D009844">Oligosaccharides</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>11096-26-7</RegistryNumber>
					<NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>30KYC7MIAI</RegistryNumber>
					<NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>GZP2782OP0</RegistryNumber>
					<NameOfSubstance UI="D019158">N-Acetylneuraminic Acid</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>PHA4727WTP</RegistryNumber>
					<NameOfSubstance UI="D008358">Mannose</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7646-65</RefSource>
					<PMID Version="1">23775885</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Protein Eng. 2001 Feb;14(2):135-40</RefSource>
					<PMID Version="1">11297671</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Am Chem Soc. 2001 Jan 31;123(4):526-33</RefSource>
					<PMID Version="1">11456564</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2003 Feb 7;299(5608):884-7</RefSource>
					<PMID Version="1">12574628</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2004 May 3;43(19):2534-8</RefSource>
					<PMID Version="1">15127445</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Am Chem Soc. 2004 Jun 2;126(21):6576-8</RefSource>
					<PMID Version="1">15161285</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Biochemistry. 1970 Dec 8;9(25):5015-23</RefSource>
					<PMID Version="1">4991411</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Biol Chem. 1987 Sep 5;262(25):12059-76</RefSource>
					<PMID Version="1">3624248</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Biol Chem. 1987 Dec 15;262(35):17156-63</RefSource>
					<PMID Version="1">3680293</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Glycobiology. 1991 Sep;1(4):337-46</RefSource>
					<PMID Version="1">1820196</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 1994 Nov 4;266(5186):776-9</RefSource>
					<PMID Version="1">7973629</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Biopolymers. 1995;37(1):17-28</RefSource>
					<PMID Version="1">7880964</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Anal Chem. 1995 Apr 15;67(8):1442-52</RefSource>
					<PMID Version="1">7741215</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 1998 Oct 1;395(6701):511-6</RefSource>
					<PMID Version="1">9774108</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Am Chem Soc. 2006 Jun 14;128(23):7460-2</RefSource>
					<PMID Version="1">16756298</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2006 Sep 8;313(5792):1441-3</RefSource>
					<PMID Version="1">16960007</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2007;46(48):9248-52</RefSource>
					<PMID Version="1">18046687</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Anal Biochem. 2008 Dec 15;383(2):243-54</RefSource>
					<PMID Version="1">18804089</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2009;48(50):9557-60</RefSource>
					<PMID Version="1">19798711</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Biotechnol. 2012 Jan;157(1):198-206</RefSource>
					<PMID Version="1">22100268</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2012 Jan 23;51(4):993-9</RefSource>
					<PMID Version="1">22180156</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2012 Apr 10;51(15):3567-72</RefSource>
					<PMID Version="1">22307754</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11566-70</RefSource>
					<PMID Version="1">22945377</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11571-5</RefSource>
					<PMID Version="1">23011954</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11576-84</RefSource>
					<PMID Version="1">23012228</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11708-13</RefSource>
					<PMID Version="1">23821753</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2013 Dec 13;342(6164):1332-3</RefSource>
					<PMID Version="1">24337286</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid
						Sequence</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001224">Aspartic Acid</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016384">Consensus
						Sequence</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response
						Relationship, Drug</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004906">Erythrocyte
						Count</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004921">Erythropoietin</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000008">administration
						&amp; dosage</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000138">chemical synthesis</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006021">Glycophorin</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006031">Glycosylation</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007279">Injections,
						Subcutaneous</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008358">Mannose</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred
						C57BL</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008969">Molecular
						Sequence Data</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019158">N-Acetylneuraminic
						Acid</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009844">Oligosaccharides</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D012156">Reticulocytes</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS604268</OtherID>
			<OtherID Source="NLM">PMC4080428</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>17</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6164/1357</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1245095</ArticleId>
				<ArticleId IdType="pubmed">24337294</ArticleId>
				<ArticleId IdType="pmc">PMC4080428</ArticleId>
				<ArticleId IdType="mid">NIHMS604268</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24337288</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>16</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>24</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>25</Day>
			</DateRevised>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6164</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>13</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Retrospective. Michael Neuberger (1953-2013).
				</ArticleTitle>
				<Pagination>
					<MedlinePgn>1335</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1248808</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Sale</LastName>
						<ForeName>Julian E</ForeName>
						<Initials>JE</Initials>
						<AffiliationInfo>
							<Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.
							</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Patel</LastName>
						<ForeName>Ketan J</ForeName>
						<Initials>KJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Batista</LastName>
						<ForeName>Facundo D</ForeName>
						<Initials>FD</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>15691</GrantID>
						<Agency>Cancer Research UK</Agency>
						<Country>United Kingdom</Country>
					</Grant>
					<Grant>
						<GrantID>MC_U105178808</GrantID>
						<Agency>Medical Research Council</Agency>
						<Country>United Kingdom</Country>
					</Grant>
					<Grant>
						<GrantID>MC_U105178811</GrantID>
						<Agency>Medical Research Council</Agency>
						<Country>United Kingdom</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D019215">Biography</PublicationType>
					<PublicationType UI="D016456">Historical Article</PublicationType>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D019477">Portraits</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D061067">Antibodies, Monoclonal,
						Humanized</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000486">Allergy and
						Immunology</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000266">history</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D061067">Antibodies,
						Monoclonal, Humanized</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000266">history</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D000916">Antibody
						Diversity</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001698">Biomedical
						Engineering</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000266">history</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" Type="Geographic"
						UI="D006113">Great Britain</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D049673">History, 20th
						Century</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D049674">History, 21st
						Century</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008967">Molecular
						Biology</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000266">history</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<PersonalNameSubjectList>
				<PersonalNameSubject>
					<LastName>Neuberger</LastName>
					<ForeName>Michael</ForeName>
					<Initials>M</Initials>
				</PersonalNameSubject>
			</PersonalNameSubjectList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>17</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6164/1335</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1248808</ArticleId>
				<ArticleId IdType="pubmed">24337288</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24336571</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>03</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>23</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>12</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6166</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>3</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Genome-scale CRISPR-Cas9 knockout screening in human
					cells.</ArticleTitle>
				<Pagination>
					<MedlinePgn>84-7</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1247005</ELocationID>
				<Abstract>
					<AbstractText>The simplicity of programming the CRISPR (clustered
						regularly interspaced short palindromic repeats)-associated
						nuclease Cas9 to modify specific genomic loci suggests a new way
						to interrogate gene function on a genome-wide scale. We show that
						lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO)
						library targeting 18,080 genes with 64,751 unique guide sequences
						enables both negative and positive selection screening in human
						cells. First, we used the GeCKO library to identify genes
						essential for cell viability in cancer and pluripotent stem cells.
						Next, in a melanoma model, we screened for genes whose loss is
						involved in resistance to vemurafenib, a therapeutic RAF
						inhibitor. Our highest-ranking candidates include previously
						validated genes NF1 and MED12, as well as novel hits NF2, CUL3,
						TADA2B, and TADA1. We observe a high level of consistency between
						independent guide RNAs targeting the same gene and a high rate of
						hit confirmation, demonstrating the promise of genome-scale
						screening with Cas9.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Shalem</LastName>
						<ForeName>Ophir</ForeName>
						<Initials>O</Initials>
						<AffiliationInfo>
							<Affiliation>Broad Institute of MIT and Harvard, 7 Cambridge
								Center, Cambridge, MA 02142, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sanjana</LastName>
						<ForeName>Neville E</ForeName>
						<Initials>NE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hartenian</LastName>
						<ForeName>Ella</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Shi</LastName>
						<ForeName>Xi</ForeName>
						<Initials>X</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Scott</LastName>
						<ForeName>David A</ForeName>
						<Initials>DA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mikkelsen</LastName>
						<ForeName>Tarjei S</ForeName>
						<Initials>TS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Heckl</LastName>
						<ForeName>Dirk</ForeName>
						<Initials>D</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ebert</LastName>
						<ForeName>Benjamin L</ForeName>
						<Initials>BL</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Root</LastName>
						<ForeName>David E</ForeName>
						<Initials>DE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Doench</LastName>
						<ForeName>John G</ForeName>
						<Initials>JG</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhang</LastName>
						<ForeName>Feng</ForeName>
						<Initials>F</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>1DP1-MH100706</GrantID>
						<Acronym>DP</Acronym>
						<Agency>NCCDPHP CDC HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>1R01-DK097768</GrantID>
						<Acronym>DK</Acronym>
						<Agency>NIDDK NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>DP1 MH100706</GrantID>
						<Acronym>MH</Acronym>
						<Agency>NIMH NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 DK097768</GrantID>
						<Acronym>DK</Acronym>
						<Agency>NIDDK NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>12</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D048868">Adaptor Proteins, Signal
						Transducing</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C503645">CUL3 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D044842">Cullin Proteins</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C460107">MED12 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D056892">Mediator Complex</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C551177">PLX4032</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C534292">TADA2B protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.11.1</RegistryNumber>
					<NameOfSubstance UI="D048490">raf Kinases</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.4.22.-</RegistryNumber>
					<NameOfSubstance UI="D053453">Caspase 9</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Methods. 2013 Oct;10(10):973-6</RefSource>
					<PMID Version="1">23892895</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Sep 12;154(6):1380-9</RefSource>
					<PMID Version="1">23992846</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Biotechnol. 2013 Sep;31(9):833-8</RefSource>
					<PMID Version="1">23907171</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Biotechnol. 2013 Sep;31(9):827-32</RefSource>
					<PMID Version="1">23873081</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2013 Aug 22;500(7463):472-6</RefSource>
					<PMID Version="1">23877069</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Jul 18;154(2):442-51</RefSource>
					<PMID Version="1">23849981</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Discov. 2013 Mar;3(3):350-62</RefSource>
					<PMID Version="1">23288408</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource>
					<PMID Version="1">23287722</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource>
					<PMID Version="1">23287718</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2012 Nov 21;151(5):937-50</RefSource>
					<PMID Version="1">23178117</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2012 Aug 17;337(6096):816-21</RefSource>
					<PMID Version="1">22745249</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2011 Feb 10;470(7333):187-97</RefSource>
					<PMID Version="1">21307931</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2010 Nov 19;330(6007):1104-7</RefSource>
					<PMID Version="1">20947725</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2010 Aug 26;363(9):809-19</RefSource>
					<PMID Version="1">20818844</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2009 Nov 27;326(5957):1231-5</RefSource>
					<PMID Version="1">19965467</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20380-5</RefSource>
					<PMID Version="1">19091943</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 2008 Jan;28(1):108-21</RefSource>
					<PMID Version="1">17967894</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Methods. 2006 Oct;3(10):777-9</RefSource>
					<PMID Version="1">16990807</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>RNA. 2006 Jul;12(7):1179-87</RefSource>
					<PMID Version="1">16682560</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>
					<PMID Version="1">16199517</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Biotechnol. 1996 Dec;14(13):1649</RefSource>
					<PMID Version="1">9634840</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2004 Mar 25;428(6981):431-7</RefSource>
					<PMID Version="1">15042092</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2004 Mar 25;428(6981):427-31</RefSource>
					<PMID Version="1">15042091</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2004 Feb 6;303(5659):832-5</RefSource>
					<PMID Version="1">14764878</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2002 Jun 27;417(6892):949-54</RefSource>
					<PMID Version="1">12068308</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Clin Oncol. 2013 Nov;10(11):616-24</RefSource>
					<PMID Version="1">23939548</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Methods. 2013 Oct;10(10):977-9</RefSource>
					<PMID Version="1">23892898</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D048868">Adaptor
						Proteins, Signal Transducing</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D053453">Caspase 9</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D064112">Clustered
						Regularly Interspaced Short Palindromic Repeats</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D044842">Cullin Proteins</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019008">Drug Resistance,
						Neoplasm</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D055786">Gene Knockout
						Techniques</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D015723">Gene Library</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016514">Genes,
						Neurofibromatosis 1</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016515">Genes,
						Neurofibromatosis 2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D056426">Genetic Loci</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005820">Genetic Testing</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D055106">Genome-Wide
						Association Study</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007211">Indoles</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016086">Lentivirus</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D056892">Mediator Complex</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008545">Melanoma</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D039904">Pluripotent Stem
						Cells</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D047428">Protein Kinase
						Inhibitors</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D012641">Selection,
						Genetic</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013449">Sulfonamides</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014157">Transcription
						Factors</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D048490">raf Kinases</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS609112</OtherID>
			<OtherID Source="NLM">PMC4089965</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>17</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1247005</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1247005</ArticleId>
				<ArticleId IdType="pubmed">24336571</ArticleId>
				<ArticleId IdType="pmc">PMC4089965</ArticleId>
				<ArticleId IdType="mid">NIHMS609112</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24336570</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>10</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>23</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>12</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6167</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>10</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Mutational analysis reveals the origin and
					therapy-driven evolution of recurrent glioma.</ArticleTitle>
				<Pagination>
					<MedlinePgn>189-93</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1239947</ELocationID>
				<Abstract>
					<AbstractText>Tumor recurrence is a leading cause of cancer
						mortality. Therapies for recurrent disease may fail, at least in
						part, because the genomic alterations driving the growth of
						recurrences are distinct from those in the initial tumor. To
						explore this hypothesis, we sequenced the exomes of 23 initial
						low-grade gliomas and recurrent tumors resected from the same
						patients. In 43% of cases, at least half of the mutations in the
						initial tumor were undetected at recurrence, including driver
						mutations in TP53, ATRX, SMARCA4, and BRAF; this suggests that
						recurrent tumors are often seeded by cells derived from the
						initial tumor at a very early stage of their evolution. Notably,
						tumors from 6 of 10 patients treated with the chemotherapeutic
						drug temozolomide (TMZ) followed an alternative evolutionary path
						to high-grade glioma. At recurrence, these tumors were
						hypermutated and harbored driver mutations in the RB
						(retinoblastoma) and Akt-mTOR (mammalian target of rapamycin)
						pathways that bore the signature of TMZ-induced mutagenesis.
					</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Johnson</LastName>
						<ForeName>Brett E</ForeName>
						<Initials>BE</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Neurological Surgery, University of
								California, San Francisco, CA 94158, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mazor</LastName>
						<ForeName>Tali</ForeName>
						<Initials>T</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hong</LastName>
						<ForeName>Chibo</ForeName>
						<Initials>C</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Barnes</LastName>
						<ForeName>Michael</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Aihara</LastName>
						<ForeName>Koki</ForeName>
						<Initials>K</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>McLean</LastName>
						<ForeName>Cory Y</ForeName>
						<Initials>CY</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fouse</LastName>
						<ForeName>Shaun D</ForeName>
						<Initials>SD</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yamamoto</LastName>
						<ForeName>Shogo</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ueda</LastName>
						<ForeName>Hiroki</ForeName>
						<Initials>H</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Tatsuno</LastName>
						<ForeName>Kenji</ForeName>
						<Initials>K</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Asthana</LastName>
						<ForeName>Saurabh</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Jalbert</LastName>
						<ForeName>Llewellyn E</ForeName>
						<Initials>LE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Nelson</LastName>
						<ForeName>Sarah J</ForeName>
						<Initials>SJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Bollen</LastName>
						<ForeName>Andrew W</ForeName>
						<Initials>AW</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Gustafson</LastName>
						<ForeName>W Clay</ForeName>
						<Initials>WC</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Charron</LastName>
						<ForeName>Elise</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Weiss</LastName>
						<ForeName>William A</ForeName>
						<Initials>WA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Smirnov</LastName>
						<ForeName>Ivan V</ForeName>
						<Initials>IV</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Song</LastName>
						<ForeName>Jun S</ForeName>
						<Initials>JS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Olshen</LastName>
						<ForeName>Adam B</ForeName>
						<Initials>AB</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Cha</LastName>
						<ForeName>Soonmee</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhao</LastName>
						<ForeName>Yongjun</ForeName>
						<Initials>Y</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Moore</LastName>
						<ForeName>Richard A</ForeName>
						<Initials>RA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mungall</LastName>
						<ForeName>Andrew J</ForeName>
						<Initials>AJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Jones</LastName>
						<ForeName>Steven J M</ForeName>
						<Initials>SJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hirst</LastName>
						<ForeName>Martin</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Marra</LastName>
						<ForeName>Marco A</ForeName>
						<Initials>MA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Saito</LastName>
						<ForeName>Nobuhito</ForeName>
						<Initials>N</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Aburatani</LastName>
						<ForeName>Hiroyuki</ForeName>
						<Initials>H</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mukasa</LastName>
						<ForeName>Akitake</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Berger</LastName>
						<ForeName>Mitchel S</ForeName>
						<Initials>MS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Susan M</ForeName>
						<Initials>SM</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Taylor</LastName>
						<ForeName>Barry S</ForeName>
						<Initials>BS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Costello</LastName>
						<ForeName>Joseph F</ForeName>
						<Initials>JF</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>1T32CA15102201</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>K08 NS079485</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>K08NS079485</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01CA81403</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P30CA82103</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P50 CA097257</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P50CA097257</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 CA163336</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 CA169316</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01CA163336</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01CA169316-01</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R25NS070680</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>T32 CA128583</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>T32GM008568</GrantID>
						<Acronym>GM</Acronym>
						<Agency>NIGMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>12</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D018906">Antineoplastic Agents,
						Alkylating</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>7GR28W0FJI</RegistryNumber>
					<NameOfSubstance UI="D003606">Dacarbazine</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>85622-93-1</RegistryNumber>
					<NameOfSubstance UI="C047246">temozolomide</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.1.1</RegistryNumber>
					<NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.1.1</RegistryNumber>
					<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.11.1</RegistryNumber>
					<NameOfSubstance UI="C482119">BRAF protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.11.1</RegistryNumber>
					<NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.11.1</RegistryNumber>
					<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.6.1.-</RegistryNumber>
					<NameOfSubstance UI="C084108">SMARCA4 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.6.4.-</RegistryNumber>
					<NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.6.4.12</RegistryNumber>
					<NameOfSubstance UI="C092332">ATRX protein, human</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.11</RefSource>
					<PMID Version="1">18428421</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Hum Mutat. 2008 May;29(5):617-22</RefSource>
					<PMID Version="1">18386774</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6</RefSource>
					<PMID Version="1">18723673</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>PLoS One. 2008;3(9):e3179</RefSource>
					<PMID Version="1">18784837</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2008 Oct 23;455(7216):1061-8</RefSource>
					<PMID Version="1">18772890</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Am J Pathol. 2009 Apr;174(4):1149-53</RefSource>
					<PMID Version="1">19246647</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Bioinformatics. 2009 May 1;25(9):1105-11</RefSource>
					<PMID Version="1">19289445</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Bioinformatics. 2009 Jul 15;25(14):1754-60</RefSource>
					<PMID Version="1">19451168</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 2009 Jul 15;15(14):4622-9</RefSource>
					<PMID Version="1">19584161</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Bioinformatics. 2009 Nov 1;25(21):2865-71</RefSource>
					<PMID Version="1">19561018</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Oncogene. 2010 May 6;29(18):2746-52</RefSource>
					<PMID Version="1">20190810</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Biotechnol. 2010 May;28(5):511-5</RefSource>
					<PMID Version="1">20436464</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>BMC Bioinformatics. 2010;11:230</RefSource>
					<PMID Version="1">20459626</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2010 Jul 8;466(7303):253-7</RefSource>
					<PMID Version="1">20613842</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Genome Res. 2010 Sep;20(9):1297-303</RefSource>
					<PMID Version="1">20644199</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nucleic Acids Res. 2010 Sep;38(16):e164</RefSource>
					<PMID Version="1">20601685</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5</RefSource>
					<PMID Version="1">20837533</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Methods. 2010 Oct;7(10):843-7</RefSource>
					<PMID Version="1">20835245</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Cancer. 2010 Oct 12;103(8):1139-43</RefSource>
					<PMID Version="1">20877357</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2010 Oct 14;363(16):1532-43</RefSource>
					<PMID Version="1">20942669</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2010 Oct 28;467(7319):1061-73</RefSource>
					<PMID Version="1">20981092</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2010 Oct 28;467(7319):1114-7</RefSource>
					<PMID Version="1">20981102</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Natl Cancer Inst. 2011 Jan 19;103(2):143-53</RefSource>
					<PMID Version="1">21163902</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2011 Feb 10;470(7333):214-20</RefSource>
					<PMID Version="1">21307934</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2011 Mar 24;471(7339):467-72</RefSource>
					<PMID Version="1">21430775</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Genet. 2011 May;43(5):491-8</RefSource>
					<PMID Version="1">21478889</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Neurosci. 2011 Sep;12(9):495-508</RefSource>
					<PMID Version="1">21811295</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Neurosurg. 2011 Nov;115(5):948-65</RefSource>
					<PMID Version="1">22043865</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Jan 19;481(7381):306-13</RefSource>
					<PMID Version="1">22258609</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Jan 26;481(7382):506-10</RefSource>
					<PMID Version="1">22237025</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6</RefSource>
					<PMID Version="1">22323597</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Feb 23;482(7386):529-33</RefSource>
					<PMID Version="1">22343890</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2012 Mar 8;366(10):883-92</RefSource>
					<PMID Version="1">22397650</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2012 May 25;149(5):994-1007</RefSource>
					<PMID Version="1">22608083</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Oncotarget. 2012 Jul;3(7):709-22</RefSource>
					<PMID Version="1">22869205</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Feb 14;152(4):714-26</RefSource>
					<PMID Version="1">23415222</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Biotechnol. 2013 Mar;31(3):213-9</RefSource>
					<PMID Version="1">23396013</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14</RefSource>
					<PMID Version="1">23412337</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 May 3;340(6132):626-30</RefSource>
					<PMID Version="1">23558169</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Methods Mol Biol. 2000;132:365-86</RefSource>
					<PMID Version="1">10547847</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2000 Jun 15;60(12):3147-51</RefSource>
					<PMID Version="1">10866302</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):545-51</RefSource>
					<PMID Version="1">12815001</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Hum Mutat. 2004 Feb;23(2):193-202</RefSource>
					<PMID Version="1">14722923</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arch Ophthalmol. 2004 Feb;122(2):239-48</RefSource>
					<PMID Version="1">14769601</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Lab Invest. 2004 Aug;84(8):941-51</RefSource>
					<PMID Version="1">15184909</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Genes Dev. 1992 Jun;6(6):953-64</RefSource>
					<PMID Version="1">1534305</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 1994 Aug 15;54(16):4299-303</RefSource>
					<PMID Version="1">8044775</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 1995 Jun 8;375(6531):506-10</RefSource>
					<PMID Version="1">7777061</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 1997 Apr;3(4):523-30</RefSource>
					<PMID Version="1">9815715</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Invest Dermatol. 1998 Dec;111(6):1202-6</RefSource>
					<PMID Version="1">9856841</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 1999 Feb 15;59(4):793-7</RefSource>
					<PMID Version="1">10029064</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7</RefSource>
					<PMID Version="1">15647370</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>
					<PMID Version="1">16199517</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2006 Apr 15;66(8):3987-91</RefSource>
					<PMID Version="1">16618716</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Cancer. 2006 Dec;6(12):924-35</RefSource>
					<PMID Version="1">17109012</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2007 Mar 8;446(7132):153-8</RefSource>
					<PMID Version="1">17344846</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 2007 Apr 1;13(7):2038-45</RefSource>
					<PMID Version="1">17404084</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Bioinformatics. 2007 Mar 15;23(6):657-63</RefSource>
					<PMID Version="1">17234643</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Annu Rev Pathol. 2006;1:97-117</RefSource>
					<PMID Version="1">18039109</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2008 May 15;68(10):3689-96</RefSource>
					<PMID Version="1">18483251</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D018906">Antineoplastic
						Agents, Alkylating</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004265">DNA Helicases</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004252">DNA Mutational
						Analysis</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D003606">Dacarbazine</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp;
						derivatives</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016296">Mutagenesis</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D060787">Neoplasm Grading</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm
						Recurrence, Local</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009687">Nuclear Proteins</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D048493">Proto-Oncogene
						Proteins B-raf</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051057">Proto-Oncogene
						Proteins c-akt</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D058570">TOR
						Serine-Threonine Kinases</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014157">Transcription
						Factors</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016159">Tumor Suppressor
						Protein p53</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS569639</OtherID>
			<OtherID Source="NLM">PMC3998672</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>17</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1239947</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1239947</ArticleId>
				<ArticleId IdType="pubmed">24336570</ArticleId>
				<ArticleId IdType="pmc">PMC3998672</ArticleId>
				<ArticleId IdType="mid">NIHMS569639</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24311695</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>06</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>23</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6163</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>6</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Single-cell metabolomics: analytical and biological
					perspectives.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1243259</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1243259</ELocationID>
				<Abstract>
					<AbstractText>There is currently much interest in broad molecular
						profiling of single cells; a cell's metabolome-its full complement
						of small-molecule metabolites-is a direct indicator of phenotypic
						diversity of single cells and a nearly immediate readout of how
						cells react to environmental influences. However, the metabolome
						is very difficult to measure at the single-cell level because of
						rapid metabolic dynamics, the structural diversity of the
						molecules, and the inability to amplify or tag small-molecule
						metabolites. Measurement techniques including mass spectrometry,
						capillary electrophoresis, and, to a lesser extent, optical
						spectroscopy and fluorescence detection have led to impressive
						advances in single-cell metabolomics. Even though none of these
						methodologies can currently measure the metabolome of a single
						cell completely, rapidly, and nondestructively, progress has been
						sufficient such that the field is witnessing a shift from
						feasibility studies to investigations that yield new biological
						insight. Particularly interesting fields of application are cancer
						biology, stem cell research, and monitoring of xenobiotics and
						drugs in tissue sections at the single-cell level.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Zenobi</LastName>
						<ForeName>R</ForeName>
						<Initials>R</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Chemistry and Applied Biosciences, ETH
								Zürich, CH-8093 Zürich, Switzerland.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
					<PublicationType UI="D016454">Review</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D015374">Biosensing
						Techniques</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019075">Electrophoresis,
						Capillary</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005838">Genotype</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013058">Mass
						Spectrometry</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D055442">Metabolome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D055432">Metabolomics</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D044085">Microfluidics</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D049329">Nanostructures</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D059010">Single-Cell
						Analysis</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013057">Spectrum
						Analysis</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6163/1243259</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1243259</ArticleId>
				<ArticleId IdType="pubmed">24311695</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24311678</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>06</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>23</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6163</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>6</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Science &amp; SciLifeLab Prize. Evolution of
					vertebrate transcriptional regulator binding.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1186</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1247569</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Schmidt</LastName>
						<ForeName>Dominic</ForeName>
						<Initials>D</Initials>
						<AffiliationInfo>
							<Affiliation>L.E.K. Consulting, 40 Grosvenor Place, London, SW1X
								7JL, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<Agency>Cancer Research UK</Agency>
						<Country>United Kingdom</Country>
					</Grant>
					<Grant>
						<Agency>Wellcome Trust</Agency>
						<Country>United Kingdom</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D019215">Biography</PublicationType>
					<PublicationType UI="D003160">Comparative Study</PublicationType>
					<PublicationType UI="D016456">Historical Article</PublicationType>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D019477">Portraits</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D022762">CCAAT-Enhancer-Binding Proteins</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C109778">CCCTC-binding factor</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C515848">CEBPA protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C530718">CEBPA protein, mouse</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C496592">HNF4A protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D051557">Hepatocyte Nuclear Factor 4</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C496593">Hnf4a protein, mouse</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D018626">Retroelements</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>9007-49-2</RegistryNumber>
					<NameOfSubstance UI="D004247">DNA</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001363">Awards and
						Prizes</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D022762">CCAAT-Enhancer-Binding
						Proteins</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004247">DNA</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019143">Evolution,
						Molecular</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051557">Hepatocyte
						Nuclear Factor 4</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D049674">History, 21st
						Century</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D012097">Repressor
						Proteins</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D018626">Retroelements</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013045">Species
						Specificity</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014714">Vertebrates</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<PersonalNameSubjectList>
				<PersonalNameSubject>
					<LastName>Schmidt</LastName>
					<ForeName>Dominic</ForeName>
					<Initials>D</Initials>
				</PersonalNameSubject>
			</PersonalNameSubjectList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6163/1186-c</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1247569</ArticleId>
				<ArticleId IdType="pubmed">24311678</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24311674</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>06</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>23</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6163</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Dec</Month>
							<Day>6</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Development. Permission to proliferate.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1183-4</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1248274</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Frede</LastName>
						<ForeName>Julia</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>MRC Cancer Unit, University of Cambridge,
								Hutchison-MRC Research Centre, Box 197, Cambridge Biomedical
								Campus, Cambridge CB2 0XZ, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Jones</LastName>
						<ForeName>Philip H</ForeName>
						<Initials>PH</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016420">Comment</PublicationType>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="CommentOn">
					<RefSource>Science. 2013 Dec 6;342(6163):1226-30</RefSource>
					<PMID Version="1">24311688</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D019898">Autocrine
						Communication</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004817">Epidermis</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000166">cytology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013234">Stem Cells</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D060449">Wnt Signaling
						Pathway</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6163/1183</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1248274</ArticleId>
				<ArticleId IdType="pubmed">24311674</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24310612</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>03</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>23</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2015</Year>
				<Month>02</Month>
				<Day>11</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6166</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>3</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Targeted therapy resistance mediated by dynamic
					regulation of extrachromosomal mutant EGFR DNA.</ArticleTitle>
				<Pagination>
					<MedlinePgn>72-6</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1241328</ELocationID>
				<Abstract>
					<AbstractText>Intratumoral heterogeneity contributes to cancer drug
						resistance, but the underlying mechanisms are not understood.
						Single-cell analyses of patient-derived models and clinical
						samples from glioblastoma patients treated with epidermal growth
						factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)
						demonstrate that tumor cells reversibly up-regulate or suppress
						mutant EGFR expression, conferring distinct cellular phenotypes to
						reach an optimal equilibrium for growth. Resistance to EGFR TKIs
						is shown to occur by elimination of mutant EGFR from
						extrachromosomal DNA. After drug withdrawal, reemergence of clonal
						EGFR mutations on extrachromosomal DNA follows. These results
						indicate a highly specific, dynamic, and adaptive route by which
						cancers can evade therapies that target oncogenes maintained on
						extrachromosomal DNA.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Nathanson</LastName>
						<ForeName>David A</ForeName>
						<Initials>DA</Initials>
						<AffiliationInfo>
							<Affiliation>Ludwig Institute for Cancer Research, University of
								California at San Diego, La Jolla, CA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Gini</LastName>
						<ForeName>Beatrice</ForeName>
						<Initials>B</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mottahedeh</LastName>
						<ForeName>Jack</ForeName>
						<Initials>J</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Visnyei</LastName>
						<ForeName>Koppany</ForeName>
						<Initials>K</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Koga</LastName>
						<ForeName>Tomoyuki</ForeName>
						<Initials>T</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Gomez</LastName>
						<ForeName>German</ForeName>
						<Initials>G</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Eskin</LastName>
						<ForeName>Ascia</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hwang</LastName>
						<ForeName>Kiwook</ForeName>
						<Initials>K</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Jun</ForeName>
						<Initials>J</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Masui</LastName>
						<ForeName>Kenta</ForeName>
						<Initials>K</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Paucar</LastName>
						<ForeName>Andres</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yang</LastName>
						<ForeName>Huijun</ForeName>
						<Initials>H</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ohashi</LastName>
						<ForeName>Minori</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhu</LastName>
						<ForeName>Shaojun</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wykosky</LastName>
						<ForeName>Jill</ForeName>
						<Initials>J</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Reed</LastName>
						<ForeName>Rachel</ForeName>
						<Initials>R</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Nelson</LastName>
						<ForeName>Stanley F</ForeName>
						<Initials>SF</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Cloughesy</LastName>
						<ForeName>Timothy F</ForeName>
						<Initials>TF</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>James</LastName>
						<ForeName>C David</ForeName>
						<Initials>CD</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Rao</LastName>
						<ForeName>P Nagesh</ForeName>
						<Initials>PN</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kornblum</LastName>
						<ForeName>Harley I</ForeName>
						<Initials>HI</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Heath</LastName>
						<ForeName>James R</ForeName>
						<Initials>JR</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Cavenee</LastName>
						<ForeName>Webster K</ForeName>
						<Initials>WK</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Furnari</LastName>
						<ForeName>Frank B</ForeName>
						<Initials>FB</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mischel</LastName>
						<ForeName>Paul S</ForeName>
						<Initials>PS</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>NS73831</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01 CA095616</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01-CA95616</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P30 CA023100</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 NS052563</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 NS052563</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 NS073831</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 NS080939</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01-NS080939</GrantID>
						<Acronym>NS</Acronym>
						<Agency>NINDS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>T32 CA009056</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>T32 CA009056</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>U54 CA151819</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>U54 CA151819</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D011799">Quinazolines</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>9007-49-2</RegistryNumber>
					<NameOfSubstance UI="D004247">DNA</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.10.1</RegistryNumber>
					<NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.10.1</RegistryNumber>
					<NameOfSubstance UI="D011958">Receptor, Epidermal Growth
						Factor</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>J4T82NDH7E</RegistryNumber>
					<NameOfSubstance UI="C400278">erlotinib</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Discov. 2012 Mar;2(3):214-26</RefSource>
					<PMID Version="1">22585993</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2012 Mar 16;148(6):1089-98</RefSource>
					<PMID Version="1">22424221</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2013 Feb 14;494(7436):251-5</RefSource>
					<PMID Version="1">23302800</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Mar 29;339(6127):1546-58</RefSource>
					<PMID Version="1">23539594</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Oncogene. 2013 May 23;32(21):2670-81</RefSource>
					<PMID Version="1">22797070</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Jul 3;154(1):61-74</RefSource>
					<PMID Version="1">23827675</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2013 Oct 1;73(19):6036-45</RefSource>
					<PMID Version="1">23940299</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83</RefSource>
					<PMID Version="1">14645703</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2000 Mar 1;60(5):1383-7</RefSource>
					<PMID Version="1">10728703</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Oct 10;155(2):462-77</RefSource>
					<PMID Version="1">24120142</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Neuropathol Exp Neurol. 2004 Jul;63(7):700-7</RefSource>
					<PMID Version="1">15290895</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11368-73</RefSource>
					<PMID Version="1">15269346</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 1978 Dec 8;202(4372):1051-5</RefSource>
					<PMID Version="1">715457</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 1981 Nov;26(3 Pt 1):355-62</RefSource>
					<PMID Version="1">7326744</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 1981 Dec;1(12):1084-93</RefSource>
					<PMID Version="1">7346713</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 1990 Jun;87(11):4207-11</RefSource>
					<PMID Version="1">1693434</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 1990 Dec 15;50(24):8017-22</RefSource>
					<PMID Version="1">2253244</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Anticancer Drugs. 1991 Feb;2(1):11-25</RefSource>
					<PMID Version="1">1720337</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8165-9</RefSource>
					<PMID Version="1">1518843</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Glia. 1995 Nov;15(3):244-56</RefSource>
					<PMID Version="1">8586461</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Brain Tumor Pathol. 2004;21(2):53-6</RefSource>
					<PMID Version="1">15700833</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 2005 Feb 15;11(4):1462-6</RefSource>
					<PMID Version="1">15746047</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Neuro Oncol. 2005 Apr;7(2):164-76</RefSource>
					<PMID Version="1">15831234</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2005 Nov 10;353(19):2012-24</RefSource>
					<PMID Version="1">16282176</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cancer Ther. 2007 Mar;6(3):1167-74</RefSource>
					<PMID Version="1">17363510</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 2008 Feb 15;14(4):957-60</RefSource>
					<PMID Version="1">18281526</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cytogenet Genome Res. 2009;124(3-4):312-26</RefSource>
					<PMID Version="1">19556783</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Brain Pathol. 2009 Oct;19(4):661-71</RefSource>
					<PMID Version="1">19744038</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Oncogene. 2010 Apr 22;29(16):2346-56</RefSource>
					<PMID Version="1">20118985</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2010 Aug 1;70(15):6128-38</RefSource>
					<PMID Version="1">20631065</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Genes Dev. 2010 Aug 15;24(16):1731-45</RefSource>
					<PMID Version="1">20713517</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2011 Jun 15;71(12):4055-60</RefSource>
					<PMID Version="1">21628493</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2011 Aug 19;146(4):633-44</RefSource>
					<PMID Version="1">21854987</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Discov. 2012 May;2(5):458-71</RefSource>
					<PMID Version="1">22588883</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic
						Agents</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016543">Central Nervous
						System Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004247">DNA</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019008">Drug Resistance,
						Neoplasm</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005909">Glioblastoma</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D058990">Molecular
						Targeted Therapy</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009368">Neoplasm
						Transplantation</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D047428">Protein Kinase
						Inhibitors</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D011799">Quinazolines</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D011958">Receptor,
						Epidermal Growth Factor</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D059010">Single-Cell
						Analysis</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells,
						Cultured</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D028761">Withholding
						Treatment</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS572551</OtherID>
			<OtherID Source="NLM">PMC4049335</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1241328</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1241328</ArticleId>
				<ArticleId IdType="pubmed">24310612</ArticleId>
				<ArticleId IdType="pmc">PMC4049335</ArticleId>
				<ArticleId IdType="mid">NIHMS572551</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24310611</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>03</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>23</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>12</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6166</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>3</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Break-induced replication repair of damaged forks
					induces genomic duplications in human cells.</ArticleTitle>
				<Pagination>
					<MedlinePgn>88-91</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1243211</ELocationID>
				<Abstract>
					<AbstractText>In budding yeast, one-ended DNA double-strand breaks
						(DSBs) and damaged replication forks are repaired by break-induced
						replication (BIR), a homologous recombination pathway that
						requires the Pol32 subunit of DNA polymerase delta. DNA
						replication stress is prevalent in cancer, but BIR has not been
						characterized in mammals. In a cyclin E overexpression model of
						DNA replication stress, POLD3, the human ortholog of POL32, was
						required for cell cycle progression and processive DNA synthesis.
						Segmental genomic duplications induced by cyclin E overexpression
						were also dependent on POLD3, as were BIR-mediated recombination
						events captured with a specialized DSB repair assay. We propose
						that BIR repairs damaged replication forks in mammals, accounting
						for the high frequency of genomic duplications in human cancers.
					</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Costantino</LastName>
						<ForeName>Lorenzo</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Molecular Biology, University of
								Geneva, 1205 Geneva, Switzerland.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sotiriou</LastName>
						<ForeName>Sotirios K</ForeName>
						<Initials>SK</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Rantala</LastName>
						<ForeName>Juha K</ForeName>
						<Initials>JK</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Magin</LastName>
						<ForeName>Simon</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mladenov</LastName>
						<ForeName>Emil</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Helleday</LastName>
						<ForeName>Thomas</ForeName>
						<Initials>T</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Haber</LastName>
						<ForeName>James E</ForeName>
						<Initials>JE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Iliakis</LastName>
						<ForeName>George</ForeName>
						<Initials>G</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kallioniemi</LastName>
						<ForeName>Olli P</ForeName>
						<Initials>OP</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Halazonetis</LastName>
						<ForeName>Thanos D</ForeName>
						<Initials>TD</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>R01 GM076020</GrantID>
						<Acronym>GM</Acronym>
						<Agency>NIGMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R37 GM020056</GrantID>
						<Acronym>GM</Acronym>
						<Agency>NIGMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D019927">Cyclin E</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.7.-</RegistryNumber>
					<NameOfSubstance UI="D004258">DNA Polymerase III</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.7.-</RegistryNumber>
					<NameOfSubstance UI="C435720">POLD3 protein, human</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2006 Nov 30;444(7119):638-42</RefSource>
					<PMID Version="1">17136094</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2007 Aug 16;448(7155):820-3</RefSource>
					<PMID Version="1">17671506</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2008 Mar 7;319(5868):1352-5</RefSource>
					<PMID Version="1">18323444</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell Cycle. 2008 Apr 1;7(7):859-64</RefSource>
					<PMID Version="1">18414031</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Chromosoma. 2008 Jun;117(3):219-33</RefSource>
					<PMID Version="1">18188578</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>PLoS Genet. 2008;4(9):e1000175</RefSource>
					<PMID Version="1">18773114</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Trends Genet. 2008 Nov;24(11):529-38</RefSource>
					<PMID Version="1">18809224</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 2009 Mar;29(6):1432-41</RefSource>
					<PMID Version="1">19139272</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2009 Oct 22;461(7267):1071-8</RefSource>
					<PMID Version="1">19847258</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2009 Dec 24;462(7276):1005-10</RefSource>
					<PMID Version="1">20033038</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Biochem Biophys Res Commun. 2010 Jan 1;391(1):542-6</RefSource>
					<PMID Version="1">19931513</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2010 Feb 18;463(7283):899-905</RefSource>
					<PMID Version="1">20164920</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Mol Cell Biol. 2010 Mar;11(3):208-19</RefSource>
					<PMID Version="1">20177396</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell. 2010 Feb 26;37(4):492-502</RefSource>
					<PMID Version="1">20188668</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Trends Biochem Sci. 2010 Jun;35(6):339-47</RefSource>
					<PMID Version="1">20163964</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2010 Oct 28;467(7319):1109-13</RefSource>
					<PMID Version="1">20981101</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2011 Apr 29;145(3):435-46</RefSource>
					<PMID Version="1">21529715</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Struct Mol Biol. 2011 Jun;18(6):721-7</RefSource>
					<PMID Version="1">21552262</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>PLoS Genet. 2012;8(4):e1002659</RefSource>
					<PMID Version="1">22532806</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Pathol. 2012 Aug;227(4):446-55</RefSource>
					<PMID Version="1">22514011</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2013 Jan 10;493(7431):246-9</RefSource>
					<PMID Version="1">23178809</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13475-80</RefSource>
					<PMID Version="1">23898170</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mutat Res. 2001 Jun 2;477(1-2):131-53</RefSource>
					<PMID Version="1">11376695</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 2004 Nov;24(21):9305-16</RefSource>
					<PMID Version="1">15485900</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 1995 May;15(5):2612-24</RefSource>
					<PMID Version="1">7739542</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Curr Genet. 1998 Oct;34(4):250-8</RefSource>
					<PMID Version="1">9799358</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 2005 Feb;25(3):933-44</RefSource>
					<PMID Version="1">15657422</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Annu Rev Biochem. 2006;75:111-35</RefSource>
					<PMID Version="1">16756487</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2006 Nov 30;444(7119):633-7</RefSource>
					<PMID Version="1">17136093</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D002453">Cell Cycle</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D019927">Cyclin E</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D053903">DNA Breaks,
						Double-Stranded</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004258">DNA Polymerase
						III</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004260">DNA Repair</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004261">DNA Replication</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D020440">Gene Duplication</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS592973</OtherID>
			<OtherID Source="NLM">PMC4047655</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1243211</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1243211</ArticleId>
				<ArticleId IdType="pubmed">24310611</ArticleId>
				<ArticleId IdType="pmc">PMC4047655</ArticleId>
				<ArticleId IdType="mid">NIHMS592973</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24310608</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>10</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>23</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>12</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6167</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>10</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Association of the autoimmune disease scleroderma with
					an immunologic response to cancer.</ArticleTitle>
				<Pagination>
					<MedlinePgn>152-7</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1246886</ELocationID>
				<Abstract>
					<AbstractText>Autoimmune diseases are thought to be initiated by
						exposures to foreign antigens that cross-react with endogenous
						molecules. Scleroderma is an autoimmune connective tissue disease
						in which patients make antibodies to a limited group of
						autoantigens, including RPC1, encoded by the POLR3A gene. As
						patients with scleroderma and antibodies against RPC1 are at
						increased risk for cancer, we hypothesized that the
						&quot;foreign&quot; antigens in this autoimmune disease are
						encoded by somatically mutated genes in the patients' incipient
						cancers. Studying cancers from scleroderma patients, we found
						genetic alterations of the POLR3A locus in six of eight patients
						with antibodies to RPC1 but not in eight patients without
						antibodies to RPC1. Analyses of peripheral blood lymphocytes and
						serum suggested that POLR3A mutations triggered cellular immunity
						and cross-reactive humoral immune responses. These results offer
						insight into the pathogenesis of scleroderma and provide support
						for the idea that acquired immunity helps to control naturally
						occurring cancers.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Joseph</LastName>
						<ForeName>Christine G</ForeName>
						<Initials>CG</Initials>
						<AffiliationInfo>
							<Affiliation>Ludwig Center, the Howard Hughes Medical
								Institutions, and the Department of Pathology, Johns Hopkins
								University School of Medicine, Baltimore, MD 21287, USA.
							</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Darrah</LastName>
						<ForeName>Erika</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Shah</LastName>
						<ForeName>Ami A</ForeName>
						<Initials>AA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Skora</LastName>
						<ForeName>Andrew D</ForeName>
						<Initials>AD</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Casciola-Rosen</LastName>
						<ForeName>Livia A</ForeName>
						<Initials>LA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wigley</LastName>
						<ForeName>Fredrick M</ForeName>
						<Initials>FM</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Boin</LastName>
						<ForeName>Francesco</ForeName>
						<Initials>F</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fava</LastName>
						<ForeName>Andrea</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Thoburn</LastName>
						<ForeName>Chris</ForeName>
						<Initials>C</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kinde</LastName>
						<ForeName>Isaac</ForeName>
						<Initials>I</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Jiao</LastName>
						<ForeName>Yuchen</ForeName>
						<Initials>Y</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Papadopoulos</LastName>
						<ForeName>Nickolas</ForeName>
						<Initials>N</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kinzler</LastName>
						<ForeName>Kenneth W</ForeName>
						<Initials>KW</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Vogelstein</LastName>
						<ForeName>Bert</ForeName>
						<Initials>B</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Rosen</LastName>
						<ForeName>Antony</ForeName>
						<Initials>A</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>CA 57345</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>CA 62924</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>CA43460</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>K23 AR061439</GrantID>
						<Acronym>AR</Acronym>
						<Agency>NIAMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>K23 AR061439</GrantID>
						<Acronym>AR</Acronym>
						<Agency>NIAMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P30 AR053503</GrantID>
						<Acronym>AR</Acronym>
						<Agency>NIAMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P30-AR053503</GrantID>
						<Acronym>AR</Acronym>
						<Agency>NIAMS NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P50 CA062924</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R37 CA043460</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R37 CA057345</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<Agency>Howard Hughes Medical Institute</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.7.-</RegistryNumber>
					<NameOfSubstance UI="D012320">RNA Polymerase III</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 2.7.7.6</RegistryNumber>
					<NameOfSubstance UI="C585825">polymerase III polypeptide A,
						human</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Ann Intern Med. 2001 Jun 19;134(12):1087-95</RefSource>
					<PMID Version="1">11412048</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arthritis Rheum. 2002 Jan;46(1):5-12</RefSource>
					<PMID Version="1">11817608</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Curr Opin Rheumatol. 2003 Nov;15(6):778-84</RefSource>
					<PMID Version="1">14569210</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Cancer. 2004 Jan;4(1):36-44</RefSource>
					<PMID Version="1">14708025</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Prog Exp Tumor Res. 1970;13:1-27</RefSource>
					<PMID Version="1">4921480</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Exp Med. 1991 Jun 1;173(6):1433-9</RefSource>
					<PMID Version="1">1851798</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Immunol. 1994 Feb 1;152(3):1453-61</RefSource>
					<PMID Version="1">8301145</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 1995 Apr 7;268(5207):106-11</RefSource>
					<PMID Version="1">7535476</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 1995 Sep 1;269(5228):1281-4</RefSource>
					<PMID Version="1">7652577</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Cancer Res Clin Oncol. 1996;122(3):135-40</RefSource>
					<PMID Version="1">8601560</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Immunol. 1999 Feb 1;162(3):1730-8</RefSource>
					<PMID Version="1">9973436</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arthritis Rheum. 1999 Apr;42(4):751-6</RefSource>
					<PMID Version="1">10211890</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 1999 May 21;284(5418):1351-4</RefSource>
					<PMID Version="1">10334988</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Biol Chem. 1999 Aug 6;274(32):22321-7</RefSource>
					<PMID Version="1">10428801</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Exp Med. 2005 Feb 21;201(4):591-601</RefSource>
					<PMID Version="1">15728237</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arthritis Rheum. 2005 May;52(5):1481-90</RefSource>
					<PMID Version="1">15880596</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Ann N Y Acad Sci. 2005 Jun;1050:1-9</RefSource>
					<PMID Version="1">16014515</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Med. 2005 Oct;11(10):1113-7</RefSource>
					<PMID Version="1">16186817</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Med. 2005 Oct;11(10):1118-24</RefSource>
					<PMID Version="1">16186818</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Med. 2006 Feb;12(2):198-206</RefSource>
					<PMID Version="1">16444264</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>PLoS Comput Biol. 2008 Apr;4(4):e1000048</RefSource>
					<PMID Version="1">18389056</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2009 May 7;360(19):1989-2003</RefSource>
					<PMID Version="1">19420368</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arthritis Rheum. 2010 Sep;62(9):2787-95</RefSource>
					<PMID Version="1">20506513</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>BMC Bioinformatics. 2010;11:568</RefSource>
					<PMID Version="1">21092157</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50</RefSource>
					<PMID Version="1">20952405</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2011 Mar 25;331(6024):1565-70</RefSource>
					<PMID Version="1">21436444</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Curr Opin Rheumatol. 2011 Nov;23(6):530-5</RefSource>
					<PMID Version="1">21825998</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2011 Dec 22;480(7378):480-9</RefSource>
					<PMID Version="1">22193102</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Feb 16;482(7385):405-9</RefSource>
					<PMID Version="1">22318517</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Feb 16;482(7385):400-4</RefSource>
					<PMID Version="1">22318521</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Dev Immunol. 2012;2012:890178</RefSource>
					<PMID Version="1">22400040</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W525-30</RefSource>
					<PMID Version="1">22610854</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Mar 29;339(6127):1546-58</RefSource>
					<PMID Version="1">23539594</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Cancer. 2013 Apr 30;108(8):1560-5</RefSource>
					<PMID Version="1">23511566</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2014 Jan 10;343(6167):147-8</RefSource>
					<PMID Version="1">24408426</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000483">Alleles</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001323">Autoantibodies</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001324">Autoantigens</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001327">Autoimmune
						Diseases</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D015551">Autoimmunity</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D015496">CD4-Positive
						T-Lymphocytes</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D056426">Genetic Loci</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D020125">Mutation,
						Missense</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D020641">Polymorphism,
						Single Nucleotide</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D012320">RNA Polymerase
						III</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D012595">Scleroderma,
						Systemic</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS582089</OtherID>
			<OtherID Source="NLM">PMC4038033</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>1</Month>
					<Day>24</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1246886</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1246886</ArticleId>
				<ArticleId IdType="pubmed">24310608</ArticleId>
				<ArticleId IdType="pmc">PMC4038033</ArticleId>
				<ArticleId IdType="mid">NIHMS582089</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24292625</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>17</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>02</Month>
				<Day>04</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2015</Year>
				<Month>01</Month>
				<Day>30</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6168</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>17</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Lenalidomide causes selective degradation of IKZF1 and
					IKZF3 in multiple myeloma cells.</ArticleTitle>
				<Pagination>
					<MedlinePgn>301-5</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1244851</ELocationID>
				<Abstract>
					<AbstractText>Lenalidomide is a drug with clinical efficacy in
						multiple myeloma and other B cell neoplasms, but its mechanism of
						action is unknown. Using quantitative proteomics, we found that
						lenalidomide causes selective ubiquitination and degradation of
						two lymphoid transcription factors, IKZF1 and IKZF3, by the
						CRBN-CRL4 ubiquitin ligase. IKZF1 and IKZF3 are essential
						transcription factors in multiple myeloma. A single amino acid
						substitution of IKZF3 conferred resistance to lenalidomide-induced
						degradation and rescued lenalidomide-induced inhibition of cell
						growth. Similarly, we found that lenalidomide-induced
						interleukin-2 production in T cells is due to depletion of IKZF1
						and IKZF3. These findings reveal a previously unknown mechanism of
						action for a therapeutic agent: alteration of the activity of an
						E3 ubiquitin ligase, leading to selective degradation of specific
						targets.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Krönke</LastName>
						<ForeName>Jan</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>Brigham and Women's Hospital, Boston, MA 02115, USA.
							</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Udeshi</LastName>
						<ForeName>Namrata D</ForeName>
						<Initials>ND</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Narla</LastName>
						<ForeName>Anupama</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Grauman</LastName>
						<ForeName>Peter</ForeName>
						<Initials>P</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hurst</LastName>
						<ForeName>Slater N</ForeName>
						<Initials>SN</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>McConkey</LastName>
						<ForeName>Marie</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Svinkina</LastName>
						<ForeName>Tanya</ForeName>
						<Initials>T</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Heckl</LastName>
						<ForeName>Dirk</ForeName>
						<Initials>D</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Comer</LastName>
						<ForeName>Eamon</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Li</LastName>
						<ForeName>Xiaoyu</ForeName>
						<Initials>X</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ciarlo</LastName>
						<ForeName>Christie</ForeName>
						<Initials>C</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Hartman</LastName>
						<ForeName>Emily</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Munshi</LastName>
						<ForeName>Nikhil</ForeName>
						<Initials>N</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Schenone</LastName>
						<ForeName>Monica</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Schreiber</LastName>
						<ForeName>Stuart L</ForeName>
						<Initials>SL</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Carr</LastName>
						<ForeName>Steven A</ForeName>
						<Initials>SA</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ebert</LastName>
						<ForeName>Benjamin L</ForeName>
						<Initials>BL</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>P01 CA078378</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01 CA108631</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01 CA108631</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P01 CA155258</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>P50 CA100707</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 CA050947</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 CA178264</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 HL082945</GrantID>
						<Acronym>HL</Acronym>
						<Agency>NHLBI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01HL082945</GrantID>
						<Acronym>HL</Acronym>
						<Agency>NHLBI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>RL1- HG004671</GrantID>
						<Acronym>HG</Acronym>
						<Agency>NHGRI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>29</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C497239">IKZF1 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C106285">IKZF3 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>148971-36-2</RegistryNumber>
					<NameOfSubstance UI="D051740">Ikaros Transcription Factor</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>4Z8R6ORS6L</RegistryNumber>
					<NameOfSubstance UI="D013792">Thalidomide</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>F0P408N6V4</RegistryNumber>
					<NameOfSubstance UI="C467567">lenalidomide</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Exp Med. 1998 Jun 1;187(11):1885-92</RefSource>
					<PMID Version="1">9607928</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>EMBO J. 1997 Apr 15;16(8):2004-13</RefSource>
					<PMID Version="1">9155026</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 1995 Oct 20;83(2):289-99</RefSource>
					<PMID Version="1">7585946</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Curr Opin Immunol. 1999 Apr;11(2):167-71</RefSource>
					<PMID Version="1">10322160</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2005 Dec 15;106(13):4050-3</RefSource>
					<PMID Version="1">16118317</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2006 Oct 5;443(7111):590-3</RefSource>
					<PMID Version="1">16964240</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Clin Oncol. 2006 Dec 1;24(34):5343-9</RefSource>
					<PMID Version="1">17088571</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Protoc. 2006;1(6):2650-60</RefSource>
					<PMID Version="1">17406521</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2007 Apr 5;446(7136):640-5</RefSource>
					<PMID Version="1">17410169</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2007 Apr 12;446(7137):758-64</RefSource>
					<PMID Version="1">17344859</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Protoc. 2007;2(8):1896-906</RefSource>
					<PMID Version="1">17703201</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2008 Jul 10;454(7201):226-31</RefSource>
					<PMID Version="1">18568025</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Proteomics. 2008 Sep;7(9):1587-97</RefSource>
					<PMID Version="1">18487603</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Haematol. 2009 Jan;144(2):268-70</RefSource>
					<PMID Version="1">19016725</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4617-22</RefSource>
					<PMID Version="1">19255428</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2009 Apr 9;458(7239):732-6</RefSource>
					<PMID Version="1">19360080</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Haematol. 2009 May;145(3):344-9</RefSource>
					<PMID Version="1">19245430</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Annu Rev Biochem. 2009;78:399-434</RefSource>
					<PMID Version="1">19489725</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2010 Mar 12;327(5971):1345-50</RefSource>
					<PMID Version="1">20223979</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Protoc. 2013 Oct;8(10):1950-60</RefSource>
					<PMID Version="1">24051958</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Proteomics. 2013 Mar;12(3):825-31</RefSource>
					<PMID Version="1">23266961</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Leukemia. 2012 Nov;26(11):2326-35</RefSource>
					<PMID Version="1">22552008</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 1994 Oct 7;79(1):143-56</RefSource>
					<PMID Version="1">7923373</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Cell. 2012 Jun 12;21(6):723-37</RefSource>
					<PMID Version="1">22698399</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2012 Mar 22;483(7390):484-8</RefSource>
					<PMID Version="1">22343896</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2011 Nov 3;118(18):4771-9</RefSource>
					<PMID Version="1">21860026</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Immunol. 2010 Sep;11(9):846-53</RefSource>
					<PMID Version="1">20676092</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Immunol. 2012 Aug;13(8):770-7</RefSource>
					<PMID Version="1">22751139</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2003 May 2;113(3):357-67</RefSource>
					<PMID Version="1">12732143</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Exp Med. 1991 Mar 1;173(3):699-703</RefSource>
					<PMID Version="1">1997652</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Exp Med. 2004 Jan 19;199(2):209-19</RefSource>
					<PMID Version="1">14718515</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Nat Rev Clin Oncol. 2014 Feb;11(2):65</RefSource>
					<PMID Version="1">24343667</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2014 Jan 17;343(6168):256-7</RefSource>
					<PMID Version="1">24436409</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic
						Agents</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051740">Ikaros
						Transcription Factor</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007376">Interleukin-2</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000096">biosynthesis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D059748">Proteolysis</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013792">Thalidomide</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp;
						derivatives</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D054875">Ubiquitination</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS603685</OtherID>
			<OtherID Source="NLM">PMC4077049</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>29</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>3</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>3</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>2</Month>
					<Day>5</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1244851</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1244851</ArticleId>
				<ArticleId IdType="pubmed">24292625</ArticleId>
				<ArticleId IdType="pmc">PMC4077049</ArticleId>
				<ArticleId IdType="mid">NIHMS603685</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24292623</PMID>
			<DateCreated>
				<Year>2014</Year>
				<Month>01</Month>
				<Day>17</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2014</Year>
				<Month>02</Month>
				<Day>04</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>20</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>343</Volume>
						<Issue>6168</Issue>
						<PubDate>
							<Year>2014</Year>
							<Month>Jan</Month>
							<Day>17</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>The myeloma drug lenalidomide promotes the
					cereblon-dependent destruction of Ikaros proteins.</ArticleTitle>
				<Pagination>
					<MedlinePgn>305-9</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1244917</ELocationID>
				<Abstract>
					<AbstractText>Thalidomide-like drugs such as lenalidomide are
						clinically important treatments for multiple myeloma and show
						promise for other B cell malignancies. The biochemical mechanisms
						underlying their antitumor activity are unknown. Thalidomide was
						recently shown to bind to, and inhibit, the cereblon ubiquitin
						ligase. Cereblon loss in zebrafish causes fin defects reminiscent
						of the limb defects seen in children exposed to thalidomide in
						utero. Here we show that lenalidomide-bound cereblon acquires the
						ability to target for proteasomal degradation two specific B cell
						transcription factors, Ikaros family zinc finger proteins 1 and 3
						(IKZF1 and IKZF3). Analysis of myeloma cell lines revealed that
						loss of IKZF1 and IKZF3 is both necessary and sufficient for
						lenalidomide's therapeutic effect, suggesting that the antitumor
						and teratogenic activities of thalidomide-like drugs are
						dissociable.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Lu</LastName>
						<ForeName>Gang</ForeName>
						<Initials>G</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Medical Oncology, Dana-Farber Cancer
								Institute, Boston, MA 02215, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Middleton</LastName>
						<ForeName>Richard E</ForeName>
						<Initials>RE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sun</LastName>
						<ForeName>Huahang</ForeName>
						<Initials>H</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Naniong</LastName>
						<ForeName>MarkVic</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ott</LastName>
						<ForeName>Christopher J</ForeName>
						<Initials>CJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Mitsiades</LastName>
						<ForeName>Constantine S</ForeName>
						<Initials>CS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wong</LastName>
						<ForeName>Kwok-Kin</ForeName>
						<Initials>KK</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Bradner</LastName>
						<ForeName>James E</ForeName>
						<Initials>JE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kaelin</LastName>
						<ForeName>William G</ForeName>
						<Initials>WG</Initials>
						<Suffix>Jr</Suffix>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>R01 CA068490</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R01 CA076120</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<Agency>Howard Hughes Medical Institute</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<Agency>Howard Hughes Medical Institute</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>29</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C497239">IKZF1 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="C106285">IKZF3 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D013723">Teratogens</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>148971-36-2</RegistryNumber>
					<NameOfSubstance UI="D051740">Ikaros Transcription Factor</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>4Z8R6ORS6L</RegistryNumber>
					<NameOfSubstance UI="D013792">Thalidomide</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.4.-</RegistryNumber>
					<NameOfSubstance UI="C502543">CRBN protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.4.-</RegistryNumber>
					<NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>F0P408N6V4</RegistryNumber>
					<NameOfSubstance UI="C467567">lenalidomide</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>EMBO Rep. 2002 Feb;3(2):177-82</RefSource>
					<PMID Version="1">11818338</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Cell. 2002 Apr;1(3):237-46</RefSource>
					<PMID Version="1">12086860</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Haematol. 2013 Jun;161(5):695-700</RefSource>
					<PMID Version="1">23565715</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Med. 2004 Jun;10(6):643-8</RefSource>
					<PMID Version="1">15122251</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Trends Biochem Sci. 1996 Nov;21(11):418-22</RefSource>
					<PMID Version="1">8987395</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2221-6</RefSource>
					<PMID Version="1">9122175</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Immunity. 1999 Mar;10(3):333-43</RefSource>
					<PMID Version="1">10204489</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):105-10</RefSource>
					<PMID Version="1">16373502</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Rev Cancer. 2006 Aug;6(8):593-602</RefSource>
					<PMID Version="1">16862190</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Immunity. 2007 Mar;26(3):335-44</RefSource>
					<PMID Version="1">17363301</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2008 Nov 7;322(5903):918-23</RefSource>
					<PMID Version="1">18988847</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell Cycle. 2009 Feb 1;8(3):498-504</RefSource>
					<PMID Version="1">19177017</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nature. 2009 Apr 9;458(7239):732-6</RefSource>
					<PMID Version="1">19360080</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2009 Jun 25;360(26):2719-29</RefSource>
					<PMID Version="1">19516027</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Clin Oncol. 2009 Dec 1;27(34):5713-9</RefSource>
					<PMID Version="1">19786667</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2010 Mar 12;327(5971):1345-50</RefSource>
					<PMID Version="1">20223979</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>FEBS Lett. 2010 Dec 15;584(24):4910-4</RefSource>
					<PMID Version="1">20888815</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Annu Rev Med. 2011;62:249-64</RefSource>
					<PMID Version="1">21090965</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2011 Nov 3;118(18):4771-9</RefSource>
					<PMID Version="1">21860026</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Cell. 2012 Jun 12;21(6):723-37</RefSource>
					<PMID Version="1">22698399</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Immunol. 2012 Aug;13(8):719-20</RefSource>
					<PMID Version="1">22814344</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Immunol. 2012 Aug;13(8):770-7</RefSource>
					<PMID Version="1">22751139</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2012 Oct 4;120(14):2843-52</RefSource>
					<PMID Version="1">22904298</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Leukemia. 2012 Nov;26(11):2326-35</RefSource>
					<PMID Version="1">22552008</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2013 Jan 24;121(4):624-7</RefSource>
					<PMID Version="1">23233657</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource>
					<PMID Version="1">23287718</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Science. 2013 Feb 15;339(6121):823-6</RefSource>
					<PMID Version="1">23287722</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Blood. 2013 Mar 7;121(10):1769-82</RefSource>
					<PMID Version="1">23303821</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Leuk Lymphoma. 2013 Apr;54(4):683-7</RefSource>
					<PMID Version="1">22966948</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cell. 2013 Apr 11;153(2):320-34</RefSource>
					<PMID Version="1">23582323</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Br J Haematol. 2013 Feb;160(4):487-502</RefSource>
					<PMID Version="1">23252516</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Nat Rev Clin Oncol. 2014 Feb;11(2):65</RefSource>
					<PMID Version="1">24343667</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2014 Jan 17;343(6168):256-7</RefSource>
					<PMID Version="1">24436409</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic
						Agents</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D057809">HEK293 Cells</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051740">Ikaros
						Transcription Factor</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D010447">Peptide
						Hydrolases</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D059748">Proteolysis</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013723">Teratogens</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D013792">Thalidomide</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp;
						derivatives</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS583352</OtherID>
			<OtherID Source="NLM">PMC4070318</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="aheadofprint">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>29</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>3</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>3</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2014</Year>
					<Month>2</Month>
					<Day>5</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">science.1244917</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1244917</ArticleId>
				<ArticleId IdType="pubmed">24292623</ArticleId>
				<ArticleId IdType="pmc">PMC4070318</ArticleId>
				<ArticleId IdType="mid">NIHMS583352</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24288332</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>11</Month>
				<Day>29</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>16</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>12</Month>
				<Day>02</Day>
			</DateRevised>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6162</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Nov</Month>
							<Day>29</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>27-Hydroxycholesterol links hypercholesterolemia and
					breast cancer pathophysiology.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1094-8</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1241908</ELocationID>
				<Abstract>
					<AbstractText>Hypercholesterolemia is a risk factor for estrogen
						receptor (ER)-positive breast cancers and is associated with a
						decreased response of tumors to endocrine therapies. Here, we show
						that 27-hydroxycholesterol (27HC), a primary metabolite of
						cholesterol and an ER and liver X receptor (LXR) ligand, increases
						ER-dependent growth and LXR-dependent metastasis in mouse models
						of breast cancer. The effects of cholesterol on tumor pathology
						required its conversion to 27HC by the cytochrome P450 oxidase
						CYP27A1 and were attenuated by treatment with CYP27A1 inhibitors.
						In human breast cancer specimens, CYP27A1 expression levels
						correlated with tumor grade. In high-grade tumors, both tumor
						cells and tumor-associated macrophages exhibited high expression
						levels of the enzyme. Thus, lowering circulating cholesterol
						levels or interfering with its conversion to 27HC may be a useful
						strategy to prevent and/or treat breast cancer.</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Nelson</LastName>
						<ForeName>Erik R</ForeName>
						<Initials>ER</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Pharmacology and Cancer Biology, Duke
								University School of Medicine, Durham, NC 27710, USA.
							</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wardell</LastName>
						<ForeName>Suzanne E</ForeName>
						<Initials>SE</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Jasper</LastName>
						<ForeName>Jeff S</ForeName>
						<Initials>JS</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Park</LastName>
						<ForeName>Sunghee</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Suchindran</LastName>
						<ForeName>Sunil</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Howe</LastName>
						<ForeName>Matthew K</ForeName>
						<Initials>MK</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Carver</LastName>
						<ForeName>Nicole J</ForeName>
						<Initials>NJ</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Pillai</LastName>
						<ForeName>Ruchita V</ForeName>
						<Initials>RV</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sullivan</LastName>
						<ForeName>Patrick M</ForeName>
						<Initials>PM</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sondhi</LastName>
						<ForeName>Varun</ForeName>
						<Initials>V</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Umetani</LastName>
						<ForeName>Michihisa</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Geradts</LastName>
						<ForeName>Joseph</ForeName>
						<Initials>J</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>McDonnell</LastName>
						<ForeName>Donald P</ForeName>
						<Initials>DP</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<DataBankList CompleteYN="Y">
					<DataBank>
						<DataBankName>GEO</DataBankName>
						<AccessionNumberList>
							<AccessionNumber>GSE35428</AccessionNumber>
							<AccessionNumber>GSE46924</AccessionNumber>
						</AccessionNumberList>
					</DataBank>
				</DataBankList>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>K99CA172357</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R37 DK048807</GrantID>
						<Acronym>DK</Acronym>
						<Agency>NIDDK NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>R37DK048807</GrantID>
						<Acronym>DK</Acronym>
						<Agency>NIDDK NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
					<Grant>
						<GrantID>T32 CA059365</GrantID>
						<Acronym>CA</Acronym>
						<Agency>NCI NIH HHS</Agency>
						<Country>United States</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D052061">Research Support, N.I.H.,
						Extramural</PublicationType>
					<PublicationType UI="D013486">Research Support, U.S. Gov't,
						Non-P.H.S.</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>20380-11-4</RegistryNumber>
					<NameOfSubstance UI="C076996">27-hydroxycholesterol</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 1.14.13.15</RegistryNumber>
					<NameOfSubstance UI="C506831">CYP27A1 protein, human</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 1.14.13.15</RegistryNumber>
					<NameOfSubstance UI="D053493">Cholestanetriol
						26-Monooxygenase</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Res. 2001 Apr 1;61(7):2917-22</RefSource>
					<PMID Version="1">11306468</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Lipids. 2001 Jul;36(7):701-11</RefSource>
					<PMID Version="1">11521968</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Oncogene. 2013 Feb 21;32(8):961-7</RefSource>
					<PMID Version="1">22469977</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Leukemia. 2002 Apr;16(4):508-19</RefSource>
					<PMID Version="1">11960327</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Lancet Oncol. 2002 Sep;3(9):565-74</RefSource>
					<PMID Version="1">12217794</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Clin Cancer Res. 2003 Jan;9(1):10-9</RefSource>
					<PMID Version="1">12538446</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Biochim Biophys Acta. 2003 Feb 17;1593(2-3):283-9</RefSource>
					<PMID Version="1">12581873</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Am J Pathol. 2003 Nov;163(5):2113-26</RefSource>
					<PMID Version="1">14578209</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Natl Cancer Inst. 1990 Mar 21;82(6):460-8</RefSource>
					<PMID Version="1">2313717</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Cell Biol. 1992 Mar;12(3):954-61</RefSource>
					<PMID Version="1">1312220</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Int J Epidemiol. 1993 Oct;22(5):772-80</RefSource>
					<PMID Version="1">8282454</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Biol Chem. 1997 Jul 18;272(29):17972-80</RefSource>
					<PMID Version="1">9218423</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):307-12</RefSource>
					<PMID Version="1">15980690</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Breast Cancer Res Treat. 2007 Jul;103(3):283-91</RefSource>
					<PMID Version="1">17260099</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Nat Med. 2007 Oct;13(10):1185-92</RefSource>
					<PMID Version="1">17873880</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Endocrinol. 2008 Jan;22(1):65-77</RefSource>
					<PMID Version="1">17872378</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Arch Physiol Biochem. 2008 Feb;114(1):71-83</RefSource>
					<PMID Version="1">18465361</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Semin Cancer Biol. 2008 Oct;18(5):349-55</RefSource>
					<PMID Version="1">18467122</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Clin Oncol. 2009 Mar 10;27(8):1160-7</RefSource>
					<PMID Version="1">19204204</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Endocrinology. 2010 Aug;151(8):3675-85</RefSource>
					<PMID Version="1">20501668</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Endocrinol. 2010 Nov;24(11):2218-31</RefSource>
					<PMID Version="1">20861222</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Am J Pathol. 2011 Jan;178(1):402-12</RefSource>
					<PMID Version="1">21224077</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Cancer Biol Ther. 2010 Dec 15;10(12):1240-3</RefSource>
					<PMID Version="1">20935521</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Atherosclerosis. 2011 Feb;214(2):448-55</RefSource>
					<PMID Version="1">21130455</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Clin Oncol. 2011 Apr 20;29(12):1592-8</RefSource>
					<PMID Version="1">21422422</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8</RefSource>
					<PMID Version="1">21813413</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Endocrinology. 2011 Dec;152(12):4691-705</RefSource>
					<PMID Version="1">21933863</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Mol Endocrinol. 2012 Jul;26(7):1235-48</RefSource>
					<PMID Version="1">22570330</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>Breast Cancer Res Treat. 2012 Aug;135(1):261-9</RefSource>
					<PMID Version="1">22806241</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="Cites">
					<RefSource>N Engl J Med. 2012 Nov 8;367(19):1792-802</RefSource>
					<PMID Version="1">23134381</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Nat Rev Endocrinol. 2014 Feb;10(2):65</RefSource>
					<PMID Version="1">24342886</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2013 Nov 29;342(6162):1028</RefSource>
					<PMID Version="1">24288308</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D053493">Cholestanetriol
						26-Monooxygenase</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models,
						Animal</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006888">Hydroxycholesterols</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;
						inhibitors</QualifierName>
					<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006937">Hypercholesterolemia</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014407">Tumor Cells,
						Cultured</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<OtherID Source="NLM">NIHMS545625</OtherID>
			<OtherID Source="NLM">PMC3899689</OtherID>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>30</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>30</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6162/1094</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1241908</ArticleId>
				<ArticleId IdType="pubmed">24288332</ArticleId>
				<ArticleId IdType="pmc">PMC3899689</ArticleId>
				<ArticleId IdType="mid">NIHMS545625</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24288308</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>11</Month>
				<Day>29</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>16</Day>
			</DateCompleted>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6162</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Nov</Month>
							<Day>29</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Cancer. Cholesterol forges link between obesity and
					breast cancer.</ArticleTitle>
				<Pagination>
					<MedlinePgn>1028</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.342.6162.1028</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Kaiser</LastName>
						<ForeName>Jocelyn</ForeName>
						<Initials>J</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016420">Comment</PublicationType>
					<PublicationType UI="D016433">News</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>20380-11-4</RegistryNumber>
					<NameOfSubstance UI="C076996">27-hydroxycholesterol</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="CommentOn">
					<RefSource>Science. 2013 Nov 29;342(6162):1094-8</RefSource>
					<PMID Version="1">24288332</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006888">Hydroxycholesterols</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D006937">Hypercholesterolemia</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>30</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>30</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6162/1028</ArticleId>
				<ArticleId IdType="doi">10.1126/science.342.6162.1028</ArticleId>
				<ArticleId IdType="pubmed">24288308</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Owner="NLM" Status="MEDLINE">
			<PMID Version="1">24264992</PMID>
			<DateCreated>
				<Year>2013</Year>
				<Month>11</Month>
				<Day>22</Day>
			</DateCreated>
			<DateCompleted>
				<Year>2013</Year>
				<Month>12</Month>
				<Day>16</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2014</Year>
				<Month>11</Month>
				<Day>25</Day>
			</DateRevised>
			<Article PubModel="Print">
				<Journal>
					<ISSN IssnType="Electronic">1095-9203</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>342</Volume>
						<Issue>6161</Issue>
						<PubDate>
							<Year>2013</Year>
							<Month>Nov</Month>
							<Day>22</Day>
						</PubDate>
					</JournalIssue>
					<Title>Science (New York, N.Y.)</Title>
					<ISOAbbreviation>Science</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Defining stem cell dynamics in models of intestinal
					tumor initiation.</ArticleTitle>
				<Pagination>
					<MedlinePgn>995-8</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1243148</ELocationID>
				<Abstract>
					<AbstractText>Cancer is a disease in which cells accumulate genetic
						aberrations that are believed to confer a clonal advantage over
						cells in the surrounding tissue. However, the quantitative benefit
						of frequently occurring mutations during tumor development remains
						unknown. We quantified the competitive advantage of Apc loss, Kras
						activation, and P53 mutations in the mouse intestine. Our findings
						indicate that the fate conferred by these mutations is not
						deterministic, and many mutated stem cells are replaced by
						wild-type stem cells after biased, but still stochastic events.
						Furthermore, P53 mutations display a condition-dependent
						advantage, and especially in colitis-affected intestines, clones
						harboring mutations in this gene are favored. Our work confirms
						the previously theoretical notion that the tissue architecture of
						the intestine suppresses the accumulation of mutated lineages.
					</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Vermeulen</LastName>
						<ForeName>Louis</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Cancer Research UK, Cambridge Institute, University
								of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Morrissey</LastName>
						<ForeName>Edward</ForeName>
						<Initials>E</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>van der Heijden</LastName>
						<ForeName>Maartje</ForeName>
						<Initials>M</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Nicholson</LastName>
						<ForeName>Anna M</ForeName>
						<Initials>AM</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Sottoriva</LastName>
						<ForeName>Andrea</ForeName>
						<Initials>A</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Buczacki</LastName>
						<ForeName>Simon</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kemp</LastName>
						<ForeName>Richard</ForeName>
						<Initials>R</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Tavaré</LastName>
						<ForeName>Simon</ForeName>
						<Initials>S</Initials>
					</Author>
					<Author ValidYN="Y">
						<LastName>Winton</LastName>
						<ForeName>Douglas J</ForeName>
						<Initials>DJ</Initials>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>17044</GrantID>
						<Agency>Cancer Research UK</Agency>
						<Country>United Kingdom</Country>
					</Grant>
					<Grant>
						<GrantID>19556</GrantID>
						<Agency>Cancer Research UK</Agency>
						<Country>United Kingdom</Country>
					</Grant>
					<Grant>
						<Agency>Cancer Research UK</Agency>
						<Country>United Kingdom</Country>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D013485">Research Support, Non-U.S.
						Gov't</PublicationType>
				</PublicationTypeList>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Science</MedlineTA>
				<NlmUniqueID>0404511</NlmUniqueID>
				<ISSNLinking>0036-8075</ISSNLinking>
			</MedlineJournalInfo>
			<ChemicalList>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D025601">Adenomatous Polyposis Coli
						Protein</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>0</RegistryNumber>
					<NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.6.5.2</RegistryNumber>
					<NameOfSubstance UI="C495971">Kras2 protein, mouse</NameOfSubstance>
				</Chemical>
				<Chemical>
					<RegistryNumber>EC 3.6.5.2</RegistryNumber>
					<NameOfSubstance UI="D016283">Proto-Oncogene Proteins
						p21(ras)</NameOfSubstance>
				</Chemical>
			</ChemicalList>
			<CitationSubset>IM</CitationSubset>
			<CommentsCorrectionsList>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Science. 2013 Nov 22;342(6161):938-9</RefSource>
					<PMID Version="1">24264980</PMID>
				</CommentsCorrections>
				<CommentsCorrections RefType="CommentIn">
					<RefSource>Nat Rev Cancer. 2014 Jan;14(1):5</RefSource>
					<PMID Version="1">24505614</PMID>
				</CommentsCorrections>
			</CommentsCorrectionsList>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D025601">Adenomatous
						Polyposis Coli Protein</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D002471">Cell
						Transformation, Neoplastic</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="Y" UI="D015972">Gene Expression
						Regulation, Neoplastic</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D007414">Intestinal
						Neoplasms</DescriptorName>
					<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008817">Mice, Mutant
						Strains</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D008954">Models,
						Biological</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D014411">Neoplastic Stem
						Cells</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
					<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016283">Proto-Oncogene
						Proteins p21(ras)</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D015533">Transcriptional
						Activation</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName MajorTopicYN="N" UI="D016159">Tumor Suppressor
						Protein p53</DescriptorName>
					<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="entrez">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>23</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2013</Year>
					<Month>11</Month>
					<Day>23</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>18</Day>
					<Hour>6</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pii">342/6161/995</ArticleId>
				<ArticleId IdType="doi">10.1126/science.1243148</ArticleId>
				<ArticleId IdType="pubmed">24264992</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
</PubmedArticleSet>